Intercept Pharmaceuticals
In Howard Marks's portfolio · Oaktree Capital Management
Ticker ICPT.CV
Not in the portfolio as of Q2 2026. Every quarter it shows up in a Oaktree Capital Management 13F, newest first.
| Quarter | Activity | Shares | Weight |
|---|---|---|---|
| Q1 2021 | Add 10% | 21,435,000 | 0.2% |
| Q3 2020 | Add 2% | 27,113,000 | 0.5% |
| Q2 2020 | Add 317% | 26,629,000 | 0.4% |
| Q4 2018 | Add 49% | 64,452,000 | 0.5% |
| Q3 2018 | Add 26% | 43,316,000 | 0.6% |
| Q2 2018 | Reduce 6% | 34,470,000 | 0.4% |
| Q1 2018 | Add 29% | 36,560,000 | 0.5% |
Price is the position's value divided by its shares, at the end of each quarter. Share counts are as filed; when a stock split happened, the change is measured on split-adjusted shares.